Data / Drug companies / Fluticasone propionate and salmeterol
Fluticasone propionate and salmeterol: 14 companies and 52 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fluticasone propionate and salmeterol is listed in the FDA National Drug Code Directory by 14 companies, with 52 products in commercial distribution. 19 of the products (36.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are powder; powder, metered, and the newest product started marketing on July 27, 2026.
The request: Get every company that lists fluticasone propionate and salmeterol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 52
- Generic (ANDA) products
- 19 (36.5%)
- Application numbers
- 7
- Routes
- Respiratory (inhalation)
- Brand names
- Advair Diskus, Wixela Inhub, AirDuo RespiClick
- openFDA record search
- api.fda.gov
Companies that list fluticasone propionate and salmeterol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 12 | powder; powder, metered | Authorized generics (NDA) | February 8, 2019 |
| Teva Pharmaceuticals USA, Inc. | 6 | powder; powder, metered | Generic drugs (ANDA) | March 23, 2022 |
| Remedyrepack Inc. | 5 | powder | Authorized generics (NDA) | July 27, 2025 |
| Bryant Ranch Prepack | 4 | powder, metered; powder | Authorized generics (NDA) | February 11, 2019 |
| Cipla USA Inc. | 3 | powder | Generic drugs (ANDA) | July 27, 2026 |
| GlaxoSmithKline LLC | 3 | powder | New drug applications (NDA) | March 5, 2001 |
| Hikma Pharmaceuticals USA Inc. | 3 | powder | Generic drugs (ANDA) | December 17, 2020 |
| Mylan Pharmaceuticals Inc. | 3 | powder | Generic drugs (ANDA) | February 11, 2019 |
| Prasco Laboratories | 3 | powder | Authorized generics (NDA) | February 8, 2019 |
| Teva Respiratory, LLC | 3 | powder, metered | New drug applications (NDA) | April 20, 2017 |
| Lannett Company, Inc. | 2 | powder | Generic drugs (ANDA) | January 12, 2026 |
| Preferred Pharmaceuticals Inc. | 2 | powder | Generic drugs (ANDA) | June 28, 2024 |
| Sportpharm LLC | 2 | powder | Authorized generics (NDA) | February 8, 2019 |
| Proficient Rx LP | 1 | powder | Authorized generics (NDA) | February 8, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 40 | 76.9% |
| Powder, metered | 12 | 23.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Authorized generics (NDA) | 21 | 40.4% |
| Generic drugs (ANDA) | 19 | 36.5% |
| New drug applications (NDA) | 12 | 23.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 52 |
| beta2-Adrenergic Agonist | 52 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.